Maintaining cardiac wellness: insights directly from a heart specialist
In the vast expanse of Central Asia and Eastern Europe, the burden of cardiovascular disease (CVD) remains high, and Zabaykalsky Krai, a region in Russia, is no exception. This region, with its unique geographic and socioeconomic context, faces significant challenges in managing CVD.
According to recent data, the number of CVD cases per 100,000 people in Zabaykalsky Krai increased from 615 in 2021 to 577.2 in 2023. This trend aligns with the broader pattern seen in the region, indicating ongoing but uneven improvements.
Prevention and management of CVD are crucial, and global and Russian-focused sources offer similar advice. Primary prevention involves addressing lifestyle factors such as improving diet, increasing physical activity, and quitting tobacco use. A healthy lifestyle can help prevent the development of CVD, including regular exercise, a balanced diet, avoiding smoking and excessive alcohol consumption, and limiting salt, fatty, and fried foods.
Healthcare system strengthening is another key aspect. Improving early diagnosis, treatment, and follow-up of hypertension and other major cardiovascular risk factors is crucial. The World Heart Federation stresses treating more people with hypertension to control blood pressure and reduce CVD risk by 2030.
Risk stratification and secondary prevention require special attention to patients with multiple cardiovascular conditions or high thromboembolic risk. This is particularly relevant in Russian patients with atrial fibrillation.
A lifespan approach is also essential, with prevention beginning from pregnancy through old age and targeting not only high-risk individuals but also moderate-risk groups to maximize population health benefits.
In Zabaykalsky Krai, residents with cardiovascular diseases can receive medications at a discount, but only if they are attached to a polyclinic and under the care of a therapist, cardiologist, and neurologist. Sudden changes in atmospheric pressure and temperature can lead to increased blood pressure, even for those taking medication. During such periods, a temporary increase in medication dosage may be required, but only with a doctor's approval.
Refusing treatment for asymptomatic hypertension significantly increases the risk of stroke and heart attack. Symptoms of CVD can include chest pain, difficulty with physical activity, fatigue, shortness of breath, heart palpitations, and heart rhythm disturbances. It's crucial to see a therapist or cardiologist immediately if you notice any initial signs of the discussed diseases, undergo testing for a therapy prescription, and have regular check-ups with the doctor.
Chronic nervous tension impairs the function of the cardiovascular system, and heart health is built from a young age. Negative factors accumulate in the body over time, potentially leading to disease decades later. Those who have had a myocardial infarction or stroke are provided with discounted medications for two years after the event.
In conclusion, the prevalence of CVD in Zabaykalsky Krai likely follows the higher burden pattern seen in Central Asia and Eastern Europe, with ongoing but uneven improvements. Prevention and management should focus on lifestyle modification, broadening hypertension control, targeted treatment of atrial fibrillation and comorbidities, and strengthening primary healthcare systems to effectively reduce disease impact.
- In the fight against chronic cardiovascular diseases (CVD), addressing lifestyle factors such as diet, physical activity, and quitting tobacco use is crucial for prevention, as advised by both global and Russian health and wellness sources.
- Healthcare systems should prioritize the early diagnosis, treatment, and follow-up of hypertension and other major cardiovascular risk factors, as treatment of more people with hypertension can help control blood pressure and reduce CVD risk, as emphasized by the World Heart Federation.
- For individuals with multiple cardiovascular conditions or high thromboembolic risk, risk stratification and secondary prevention require special attention, especially for Russian patients with atrial fibrillation.
